vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»10.15690/vsp.v20i5.2318vsp-2747Research ArticleОБМЕН ОПЫТОМEXCHANGE OF EXPERIENCEКлинико-социальные аспекты псориатического артрита в педиатрической практикеClinical and Social Aspects of Psoriatic Arthritis in Pediatricshttps://orcid.org/0000-0002-1450-4942БакулевА. Л.BakulevAndrey L.

410028, Саратов, ул. Провиантская, д. 22.

Saratov.

https://orcid.org/0000-0001-5599-6245ТальниковаЕ. Е.TalnikovaEkaterina E.

Тальникова Екатерина Евгеньевна - ассистент кафедры дерматовенерологии и косметологии Саратовского ГМУ им. В.И. Разумовского.410028, Саратов, ул. Провиантская, д. 22.

Saratov.

mina_tlt@mail.ruСаратовский государственный медицинский университет им. В.И. РазумовскогоРоссияSaratov State Medical University n.a. V.I. RazumovskyRussian Federation202106112021205426429Copyright © Бакулев А.Л., Тальникова Е.Е., 20212021Бакулев А.Л., Тальникова Е.Е.Bakulev A.L., Talnikova E.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/2747

Псориатический артрит является актуальной проблемой современной детской дерматологии. В обзоре освещены вопросы эпидемиологии, клинической картины, классификации, диагностики, принципов терапиии коморбидных состояний псориатического артрита, а также социальные аспекты болезни.

Psoriatic arthritis is pending issue in modern pediatric dermatology. This review highlights issues of epidemiology, clinical signs, classification, diagnosis, management of comorbid conditions of psoriatic arthritis, as well as social aspects of the disease.

псориатический артритдетикачество жизниpsoriatic arthritischildrenquality of lifeНе указан.Not specified.ReferencesМурашкин Н.Н., Материкин А.И., Амбарчян Э.Т., Епишев Р.В., Опрятин Л.А., Иванов Р.А., Куколева Д.С., Купцова Д.Г., Помазанова М.Ю. Псориаз и псориатический артрит в детском возрасте // Вопросы современной педиатрии. — 2020. — Т. 19. — № 6. — С. 444-451. doi: 10.15690/vsp.v19i6.2146Murashkin NN, Materikin AI, Ambarchian ET, Epishev RV, Opryatin LA, Ivanov RA, Kukoleva DS, Kuptsova DG, Pomazanova MU. Psoriasis and Psoriatic Arthritis in Childhood Psoriasis and Psoriatic Arthritis in Childhood. Current Pediatrics. 2020;19(6):444-451. (In Russ). doi: 10.15690/vsp.v19i6.2146Osier E, Wang AS, Tollefson MM, et al. Pediatric Psoriasis Comorbidity Screening Guidelines. JAMA Dermatol. 2017;153(7):698-704. doi: 10.1001/jamadermatol.2017.0499Osier E, Wang AS, Tollefson MM, et al. Pediatric Psoriasis Comorbidity Screening Guidelines. JAMA Dermatol. 2017;153(7):698-704. doi: 10.1001/jamadermatol.2017.0499Menter A, Cordoro KM, Davis DMR, et al. Joint American Academy of Dermatology National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol. 2020;82(1):161-201. doi: 10.1016/j.jaad.2019.08.049Menter A, Cordoro KM, Davis DMR, et al. Joint American Academy of Dermatology National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol. 2020;82(1):161-201. doi: 10.1016/j.jaad.2019.08.049Stoll ML, Mellin ED. Psoriatic arthritis in childhood: A commentary on the controversy. Clinical Immunology. 2020;214:2-7. doi: 10.1016/j.clim.2020.108396Stoll ML, Mellin ED. Psoriatic arthritis in childhood: A commentary on the controversy. Clinical Immunology. 2020;214:2-7. doi: 10.1016/j.clim.2020.108396Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973;3(1):55-78. doi: 10.1016/0049-0172(73)90035-8Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973;3(1):55-78. doi: 10.1016/0049-0172(73)90035-8Stoll ML, Punaro M. Psoriatic juvenile idiopathic arthritis: a tale of two subgroups. Curr Opin Rheumatol. 2011;23(5):437-443. doi: 10.1097/bor.0b013e328348b278Stoll ML, Punaro M. Psoriatic juvenile idiopathic arthritis: a tale of two subgroups. Curr Opin Rheumatol. 2011;23(5):437-443. doi: 10.1097/bor.0b013e328348b278Meneghetti TC, et al. The musculoskeletal impairment negatively impacts the quality of life of children and adolescents with psoriasis. Advances in Rheumatology. 2020;60:33. doi: 10.1186/s42358-020-00136-6Meneghetti TC, et al. The musculoskeletal impairment negatively impacts the quality of life of children and adolescents with psoriasis. Advances in Rheumatology. 2020;60:33. doi: 10.1186/s42358-020-00136-6Мурашкин Н.Н., Круглова Л.С., Коваленко Ю.А., Амбарчян Э.Т., Епишев Р.В., Материкин А.И., Опрятин Л.А., Иванов Р.А., Куколева Д.С., Купцова Д.Г., Помазанова М.Ю., Козырь Я.В. Коморбидности псориаза в детском возрасте // Вопросы современной педиатрии. — 2020. — Т. 19. — № 6. — С. 460-467. doi: 10.15690/vsp.v19i6.2149Murashkin NN, Kruglova LS, Kovalenko IA, Ambarchian ET, Epishev RV, Materikin AI, Opryatin LA, Ivanov RA, Kukoleva DS, Kuptsova DG, Pomazanova MYu, Kozyr YV. Psoriasis Comorbidities in Childhood. Current Pediatrics. 2020;19(6):460-467. (In Russ). doi: 10.15690/vsp.v19i6.2149Brandon TG, Manos CK, Xiao R, Ogdie A, Weiss PF. Pediatric psoriatic arthritis: a population-based cohort study of risk factors for onset and subsequent risk of inflammatory comorbidities. J Psoriasis Psoriatic Arthritis. 2018;3(4):131-136. doi: 10.1177/2475530318799072Brandon TG, Manos CK, Xiao R, Ogdie A, Weiss PF. Pediatric psoriatic arthritis: a population-based cohort study of risk factors for onset and subsequent risk of inflammatory comorbidities. J Psoriasis Psoriatic Arthritis. 2018;3(4):131-136. doi: 10.1177/2475530318799072Butbul A, et al. Juvenile Psoriatic Arthritis (JPsA): Juvenile arthritis with psoriasis? Pediatric Rheumatology. 2013;11(1):11. doi: 10.1186/1546-0096-11-11Butbul A, et al. Juvenile Psoriatic Arthritis (JPsA): Juvenile arthritis with psoriasis? Pediatric Rheumatology. 2013;11(1):11. doi: 10.1186/1546-0096-11-11Taylor W, et al. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis & Rheumatology. 2006;54(8):2665-2673. doi: 10.1002/art.21972Taylor W, et al. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis & Rheumatology. 2006;54(8):2665-2673. doi: 10.1002/art.21972Zisman D, et al. The juvenile psoriatic arthritis cohort in the CARRA registry: Clinical characteristics, classification, and outcomes. J Rheumatol. 2017;44(3):342-351. doi: 10.3899/jrheum.160717Zisman D, et al. The juvenile psoriatic arthritis cohort in the CARRA registry: Clinical characteristics, classification, and outcomes. J Rheumatol. 2017;44(3):342-351. doi: 10.3899/jrheum.160717Saurenmann RK, Rose JB, Tyrrell P, et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum. 2007;56:1974-1984. doi: 10.1002/art.22709Saurenmann RK, Rose JB, Tyrrell P, et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum. 2007;56:1974-1984. doi: 10.1002/art.22709Guillaume S, Prieur AM, Coste J, Job-Deslandre C. Longterm outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis. Arthritis Rheum. 2000;43:1858-1865. doi: 10.1002/1529-0131(200008)43:8<1858::AID-ANR23>3.0.CO;2-AGuillaume S, Prieur AM, Coste J, Job-Deslandre C. Longterm outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis. Arthritis Rheum. 2000;43:1858-1865. doi: 10.1002/1529-0131(200008)43:8<1858::AID-ANR23>3.0.CO;2-AHofer MF, Mouy R, Prieur AM. Juvenile idiopathic arthritides evaluated prospectively in a single center according to the Durban criteria. J Rheumatol. 2001;28:1083-1090.Hofer MF, Mouy R, Prieur AM. Juvenile idiopathic arthritides evaluated prospectively in a single center according to the Durban criteria. J Rheumatol. 2001;28:1083-1090.Minden K, Niewerth M, Listing J, et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum. 2002;46:2392-2401. doi: 10.1002/art.10444Minden K, Niewerth M, Listing J, et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum. 2002;46:2392-2401. doi: 10.1002/art.10444Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: Epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64: ii14-17. doi: 10.1136/ard.2004.032482Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: Epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64: ii14-17. doi: 10.1136/ard.2004.032482Rosen CF, Mussani F, Chandran V, et al. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone. Rheumatology. 2011;51:571-576. doi: 10.1093/rheumatology/ker365Rosen CF, Mussani F, Chandran V, et al. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone. Rheumatology. 2011;51:571-576. doi: 10.1093/rheumatology/ker365Orbai AM, de Wit M, Mease P, et al. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann Rheum Dis. 2017;76:673-680. doi: 10.1136/annrheumdis-2016-210242Orbai AM, de Wit M, Mease P, et al. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann Rheum Dis. 2017;76:673-680. doi: 10.1136/annrheumdis-2016-210242Ogdie A, et al. Patient's experience of psoriatic arthritis: A conceptual model based on qualitative interviews. RMD Open. 2020;6:e001321. doi: 10.1136/rmdopen-2020-001321Ogdie A, et al. Patient's experience of psoriatic arthritis: A conceptual model based on qualitative interviews. RMD Open. 2020;6:e001321. doi: 10.1136/rmdopen-2020-001321Бакулев А.Л., Тальникова Е.Е. Псориаз в педиатрической практике // Вопросы современной педиатрии. — 2020. — Т. 19. — № 6. — С. 496-499. doi: 10.15690/vsp.v19i6.2150Bakulev AL, Talnikova EE. Psoriasis in Pediatrics. Current Pediatrics. 2020;19(6):496-499. (In Russ). doi: 10.15690/vsp.v19i6.2150Varni JW, Globe DR, Gandra SR, et al. Health-related quality of life of pediatric patients with moderate to severe plaque psoriasis: Comparisons to four common chronic diseases. Eur J Pediatr. 2012;171(3):485-492. doi: 10.1007/s00431-011-1587-2Varni JW, Globe DR, Gandra SR, et al. Health-related quality of life of pediatric patients with moderate to severe plaque psoriasis: Comparisons to four common chronic diseases. Eur J Pediatr. 2012;171(3):485-492. doi: 10.1007/s00431-011-1587-2Tollefson MM, Megha M, Schoch JJ, Eton DT. Impact of childhood psoriasis on parents of affected children. J Am Acad Dermatol. 2017;76(2):286-289.e5. doi: 10.1016/j.jaad.2016.09.014Tollefson MM, Megha M, Schoch JJ, Eton DT. Impact of childhood psoriasis on parents of affected children. J Am Acad Dermatol. 2017;76(2):286-289.e5. doi: 10.1016/j.jaad.2016.09.014Edens C, Antonelli M. The Prevalence of Comorbidities in Children and Young Adults with Psoriasis and Psoriatic Arthritis. Journal of Psoriasis and Psoriatic Arthritis. 2019;4(1):22-27. doi: 10.1177/2475530318807695Edens C, Antonelli M. The Prevalence of Comorbidities in Children and Young Adults with Psoriasis and Psoriatic Arthritis. Journal of Psoriasis and Psoriatic Arthritis. 2019;4(1):22-27. doi: 10.1177/2475530318807695Coates LC, Kavanaugh A, Ritchlin CT. Systematic review of treatments for psoriatic arthritis: 2014 update for the GRAPPA. J Rheumatol. 2014;41(11):2273-2276. doi: 10.3899/jrheum.140875Coates LC, Kavanaugh A, Ritchlin CT. Systematic review of treatments for psoriatic arthritis: 2014 update for the GRAPPA. J Rheumatol. 2014;41(11):2273-2276. doi: 10.3899/jrheum.140875Оказание медицинской помощи детям с псориазом / под ред. А.А. Баранова, Л.С. Намазовой-Барановой, Н.Н. Мурашкина. — М.: ПедиатрЪ; 2016. — 64 с.Okazanie meditsinskoj pomoshchi detyam s psoriazom. Baranov AA, Namazova-Baranova LS, Murashkin NN, eds. Moscow: Pediatr; 2016. 64 p. (In Russ).Псориаз у детей: клинические рекомендации. — М.: Союз педиатров России, 2016.Psoriaz u detei: klinicheskie rekomendatsii. Moscow: Soyuz pediatrov Rossii; 2016. (In Russ).Napolitano M, Megna M, Balato A, Ayala F, Lembo S, Villani A, Balato N. Systemic Treatment of Pediatric Psoriasis: A Review. Dermatol Ther (Heidelb). 2016;6(2):125-142.Napolitano M, Megna M, Balato A, Ayala F, Lembo S, Villani A, Balato N. Systemic Treatment of Pediatric Psoriasis: A Review. Dermatol Ther (Heidelb). 2016;6(2):125-142.Намазова-Баранова Л.С., Мурашкин Н.Н., Амбарчян Э.Т., Материкин А.И. Системная терапия псориаза в детском возрасте (часть I) // Вестник дерматологии и венерологии. — 2017. — № 4. — С. 74-81.Namazova-Baranova LS, Murashkin NN, Ambarchian ET, Materikin AI. System therapy of psoriasis in children (part I). Vestnik Dermatologii i Venerologii. 2017;(4):74-81. (In Russ).Баранов А.А., Намазова-Баранова Л.С., Мурашкин Н.Н., и др. Федеральные клинические рекомендации по оказанию медицинской помощи детям с псориазом. — M., 2016. — С. 5-10.Baranov AA, Namazova-Baranova LS, Murashkin NN et al. Federal Clinical Guidelines of Care for the Management for Children with Psoriasis. Moscow; 2016. P. 5-10. (In Russ).Paller AS, Siegfried EC, Langley RG, et al. Long-Term Safety and Efficacy of Etanercept in Children and Adolescents with Plaque Psoriasis. J. Am. Acad. Dermatol. 2016;74(2):280-287. doi: 10.1016/j.jaad.2015.09.056Paller AS, Siegfried EC, Langley RG, et al. Long-Term Safety and Efficacy of Etanercept in Children and Adolescents with Plaque Psoriasis. J. Am. Acad. Dermatol. 2016;74(2):280-287. doi: 10.1016/j.jaad.2015.09.056Намазова-Баранова Л.С., Мурашкин Н.Н., Амбарчян Э.Т., Материкин А.И. Системная терапия псориаза в детском возрасте (часть II): вопросы биологической терапии // Вестник дерматологии и венерологии. — 2017. — № 6. — С. 100-107. doi: 10.25208/0042-4609-2017-93-6-100-107Namazova-Baranova LS, Murashkin NN, Ambarchian ET, Materikin AI. Systemic Psoriasis Treatment at an Early Age (part II): Issues of Biological Therapy. Vestnik Dermatologii i Venerologii. 2017;(6):100-107. (In Russ). doi: 10.25208/0042-4609-2017-93-6-100-107

The authors declare that there are no conflicts of interest present.